GlaxoSmithKline (GSK) Tops Q2 EPS by 4c

GlaxoSmithKline (NYSE: GSK) reported Q2 EPS of GBP0.25, GBP0.04 better than the analyst estimate of GBP0.21. Revenue for the quarter came in at GBP6.35 billion versus the consensus estimate of GBP6.34 billion.

For earnings history and earnings-related data on GlaxoSmithKline (GSK) click here.

You May Also Be Interested In

• Royal Caribbean to acquire 50% stake in Sandals Resorts for $3 billion
• General Mills (GIS) Tops Q1 EPS by 3c
• Oppenheimer Starts Viatris (VTRS) at Outperform